| Title |
Medical Marijuana and Driving: a Review
|
|---|---|
| Published in |
Journal of Medical Toxicology, March 2014
|
| DOI | 10.1007/s13181-014-0393-4 |
| Pubmed ID | |
| Authors |
Mark J. Neavyn, Eike Blohm, Kavita M. Babu, Steven B. Bird |
| Abstract |
Medical marijuana remains a highly debated treatment regimen despite removal of state penalties against care providers prescribing the drug and patients treated with the drug in many areas of the USA. The utility of marijuana in specific medical conditions has been studied at length, but its effects on driving performance and risk of motor vehicle collision remain unclear. As with other medications that affect psychomotor function, the healthcare provider should be informed of the potential risks of driver safety prior to prescribing this psychotropic drug to give appropriate anticipatory guidance for appropriate use. The goal of this narrative review is to assess the current literature regarding marijuana as it relates to driving performance and traffic safety. With a foundation in the pharmacology of cannabinoids, we consider the limitations of testing cannabinoid and metabolite concentration. In addition, we will review studies on driving performance and epidemiological studies implicating marijuana in motor vehicle collisions. The increasing prevalence of medical marijuana laws in the USA suggests that clinicians should be aware of marijuana's influence on public safety. Patients should abstain from driving for 8 h if they achieve a subjective "high" from self-treatment with smoked marijuana and should be aware of the cumulative effects of alcohol and other psychoactive xenobiotics. |
X Demographics
The data shown below were collected from the profiles of 27 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 9 | 33% |
| Germany | 3 | 11% |
| Canada | 3 | 11% |
| Latvia | 1 | 4% |
| United Kingdom | 1 | 4% |
| Brazil | 1 | 4% |
| Unknown | 9 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 20 | 74% |
| Practitioners (doctors, other healthcare professionals) | 5 | 19% |
| Science communicators (journalists, bloggers, editors) | 1 | 4% |
| Scientists | 1 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 4% |
| Mexico | 1 | <1% |
| Poland | 1 | <1% |
| Italy | 1 | <1% |
| Unknown | 141 | 94% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 31 | 21% |
| Other | 19 | 13% |
| Student > Master | 16 | 11% |
| Student > Bachelor | 13 | 9% |
| Student > Ph. D. Student | 12 | 8% |
| Other | 31 | 21% |
| Unknown | 28 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 36 | 24% |
| Psychology | 13 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 11 | 7% |
| Nursing and Health Professions | 9 | 6% |
| Agricultural and Biological Sciences | 9 | 6% |
| Other | 26 | 17% |
| Unknown | 46 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 48. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2024.
All research outputs
#888,313
of 25,755,403 outputs
Outputs from Journal of Medical Toxicology
#48
of 732 outputs
Outputs of similar age
#8,312
of 237,805 outputs
Outputs of similar age from Journal of Medical Toxicology
#1
of 20 outputs
Altmetric has tracked 25,755,403 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 732 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 19.5. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 237,805 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.